Current Location:HomeEarly-StageBiologics
As the technology of large molecule drug discovery platform gets more mature, for most of targets, multiple candidate molecules with expected functional activities can be obtained. At this time, taking druggability into consideration will further reduce the risk of the production processes at the later stage.
With its evaluation platform, HealSun Biopharm rapidly narrows down the screening scope of candidate molecules for clients at the early stage of drug development, obtains candidate molecules with optimal activity and suitable for pharmaceuticals, reducing the risk of later development and contributing to the success of the project.
Email:healsunbd@hs-biopharm.com
Copyright © 2023 杭州皓阳生物技术有限公司All Rights Reserved 浙ICP备16013229号-1 浙公网安备 33011002011493号 技术支持:杭州网站制作